SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome -- Ignore unavailable to you. Want to Upgrade?


To: Laurens who wrote (651)2/10/1999 2:43:00 PM
From: MARK TANAKA  Read Replies (2) | Respond to of 900
 
to all,

great quarter.

-sequential quarterly sales up, 17.6mil q3 98, to 21.9mil, q4 98.
24% increase qtr to qtr.

-cost of good sold decreasing, which increases gross margins.

selling more and making more off what they sell... positive mo

-The Company filed a New Drug Application (NDA) with the U.S. Food and Drug Administration in December 1998 for EVACET(TM).

regards,

Mark